Title

• 36 years of diverse experiences in biomedicine
• 4 years as independent consultant advising on commercialization strategy, strategic planning and market analysis in pharmaceutics & emerging technology (biomarkers, imaging and nanotechnology)
• Clients:  Global Fortune 500 pharmaceutical companies, idea-stage to small biotechnology companies, boutique intellectual-property law firm
• 1 year as Business Advisor for funding and implementation of product development for idea-stage biotechnology
• 32 years as researcher and co-principal investigator at leading biomedical and health-science research centers

Specific Areas of Expertise

• Competitive positioning strategy and commercial development strategy for business proposals and investor presentations. 
• Competitive intelligence for commercialization strategy, strategic planning and market analysis
• Assessment of technical readiness and commercial feasibility of emerging and competing technologies 
• Assistance in patent strategy
• Scientific expertise:  Biochemistry, Cell Biology, Molecular Biology, Immunology
• Therapeutic areas:  CNS, Ophthalmology, Immunology, Oncology, Metabolism
• 14 Publications

Consulting Engagements

• Emerging developments and trends in the treatment of glaucoma
• Emerging developments and trends in the treatment and diagnosis of Alzheimer’s disease
• Regulatory issues in clinical trials for the treatment of Alzheimer’s disease: use of biomarkers, and clinical trial design
• Marketing strategy for implementation of nanotechnology for drug delivery as a product line extension
• Health-care reform in China:  implications for multinational pharmaceutical companies
• Technical review of patent prosecution history for invalidation opinion
• Recommendation of marketable business opportunities worthy of patent prosecution for regulated self-assembly of  proteins
• Gene barcode for microarray analysis – business guidance for market analysis
• Multiplexed molecular diagnostic tests for detection of infectious diseases – business guidance for market analysis
• EM-CCD cameras for single molecule spectroscopy and imaging – market advisory
• Targeted inhibition of cancer stem cells – business guidance on proposal development (business plan and investor pitch) to fund proof-of-concept study for a potentially immunotherapeutic discovery
• Nanotechnology-enabled lab-on-a chip for rapid detection of micro RNA – secured funding and provided business guidance for product development, including go-to-market exit strategy

Professional Positions & Activities

• Business Advisor, QED Proof-of-Concept Program)                                          University City Science Center
• Research Assistant Professor/Adjunct Professor                                               Thomas Jefferson University
• Research Assistant Professor/Adjunct Professor                                               Wistar Institute
• Research Assistant Professor/Adjunct Professor               University of Pennsylvania School of Medicine
• Children’s Hospital of Philadelphia                                           Research Assistant Professor/Adjunct Professor